Biogen Diagnostica

What Biogen Diagnostica does

Biogen Diagnóstica S.L. is a privately held Spanish medical technology company founded in 1998 that distributes medical devices, reagents, and advanced solutions to hospitals, laboratories, and research centers across Spain and Portugal. The company operates a six-category product portfolio spanning interventional cardiology and hemodynamics (closure systems, diagnostic and interventional catheters, PTCA balloons, stents, valvuloplasty), cardiac electrophysiology and stimulation (ablation systems, temporary pacemakers, stimulation cables), cardiac surgery and extracorporeal support (cannulation, oxygenators, perfusion sets), peripheral and venous vascular intervention, critical care (non-invasive hemodynamic monitoring), and laboratory diagnostics (including veterinary products). Biogen Diagnóstica combines exclusive or semi-exclusive distribution of leading international brands (OSYPKA, Terumo, Boditech, cNovate, GENOSS, Invamed, Meise Medizintechnik, Spectrum Medical, Bioptimal) with its own proprietary R&D, producing branded devices such as the ICONCore® non-invasive cardiometer, VACS® II and III balloon dilation catheters, and the CoraSim® cardiac simulator for electrophysiology training.

The company runs an enterprise field-sales go-to-market motion with direct commercial relationships to hospitals and laboratories, supported by quote-based B2B pricing and multi-year contracts; pricing is not publicly disclosed. Operating geographies are limited to the Iberian Peninsula (Spain and Portugal). Biogen Diagnóstica holds ISO 9001:2015 (2023) and ISO 14001:2015 (2025) certifications for quality and environmental management, indicating compliance posture suited to public hospital procurement. The company has no disclosed revenue, headcount, ownership investors, or M&A activity in the available source data, and operates with no parent company, no public listing, and no documented AI/ML capabilities across its product set.

Name

Biogen Diagnostica

Legal name

Biogen Diagnóstica S.L.

Website

https://biogen-diagnostica.es

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Biogen Diagnóstica S.L. is a privately held Spanish medical technology distributor founded in 1998, supplying cardiovascular, electrophysiology, cardiac surgery, vascular, critical care, and laboratory diagnostic devices to hospitals, laboratories, and research centers in Spain and Portugal, combining international brand distribution with proprietary R&D products.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device Distribution: Distribution of medical devices, reagents, and advanced solutions to hospitals, laboratories, and research centers in Spain and Portugal, representing leading international brands alongside proprietary R&D developed products.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Biogen Diagnóstica distributes and develops medical devices, reagents, and advanced solutions for cardiovascular diagnosis, prevention, treatment, and patient care. The portfolio covers interventional cardiology, cardiac electrophysiology and stimulation, cardiac surgery and extracorporeal support, peripheral and venous vascular intervention, critical care monitoring, and laboratory diagnostics, combining proprietary R&D-developed branded products (ICONCore, VACS, CoraSim) with distribution of leading international medical technology brands for hospitals, laboratories, and research centers in Spain and Portugal.

Product overview

Biogen Diagnóstica is a medical technology company with 20-25 years of experience distributing medical devices, reagents, and advanced solutions for hospitals, laboratories, and research centers in Spain and Portugal. The portfolio is organized into six main product categories: (1) Interventional Cardiology-Hemodynamics covering closure systems, diagnostic and interventional catheters, PTCA balloons, stents, and valvuloplasty products including the VACS® II and III balloon catheters; (2) Cardiac Electrophysiology and Stimulation including ablation systems, temporary pacemakers (OSYPKA PACE 101H single-chamber and OSYPKA PACE 300 three-chamber), stimulation cables, and the CoraSim® cardiac simulator for training; (3) Cardiac Surgery and Extracorporeal Support with cardioplegia cannulas, oxygenators, and perfusion sets; (4) Peripheral/Venous Vascular Surgery and Intervention for conditions like DVT and peripheral arterial disease; (5) Critical Care featuring the ICONCore® non-invasive hemodynamic monitor; and (6) Laboratory and Diagnostics including blood collection tubes and veterinary products. The company also distributes products from brands including Bioptimal, Boditech, cNovate, GENOSS, Invamed, Meise Medizintechnik GmbH, OSYPKA, Osypka Medical, Spectrum Medical, and Terumo, with its own R&D development capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• ICONCore: Non-invasive cardiometer for continuous hemodynamic parameter measurement in neonates, children, and adults.
• VACS
• CoraSim

Products and services

• Interventional Cardiology and Hemodynamics Product Line

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core.

• OSYPKAcoreTechnology or IntegrationDistribution partnership for OSYPKA external pacemakers including PACE 101H and PACE 300 models for cardiac stimulation applications in Spain and Portugal.
• OSYPKA MedicalcoreTechnology or IntegrationDistribution partnership for Osypka Medical products in the Spanish and Portuguese markets.
• TerumocoreTechnology or IntegrationDistribution partnership for Terumo medical devices in Spain and Portugal.
• BoditechcoreTechnology or IntegrationDistribution partnership for Boditech diagnostic products in the Spanish and Portuguese markets.
• cNovatecoreTechnology or IntegrationDistribution partnership for cNovate products in Spain and Portugal.
• GENOSScoreTechnology or IntegrationDistribution partnership for GENOSS medical devices in the Spanish and Portuguese markets.
• InvamedcoreTechnology or IntegrationDistribution partnership for Invamed products in Spain and Portugal.
• Meise Medizintechnik GmbHcoreTechnology or IntegrationDistribution partnership for Meise Medizintechnik products in the Spanish and Portuguese markets.
• Spectrum MedicalcoreTechnology or IntegrationDistribution partnership for Spectrum Medical products in Spain and Portugal.
• BioptimalcoreTechnology or IntegrationDistribution partnership for Bioptimal brand products in the Spanish and Portuguese markets.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Medtronic: Medtronic is a global leader in cardiovascular, cardiac surgery, and electrophysiology devices with direct sales operations across Iberia. It competes with Biogen's principals (some of which Biogen distributes) and with Biogen's own proprietary portfolio in the same hospital accounts.
• Boston Scientific: Boston Scientific has a meaningful cardiovascular and electrophysiology franchise and direct presence in Spain and Portugal. It represents the type of broad incumbent whose products Biogen's customers may purchase directly or through competing distributors.
• B. Braun: B. Braun manufactures and distributes a broad portfolio of medical devices, IV systems, and surgical products with established operations in Spain and Portugal. Its cardiovascular, surgical, and hospital supply footprint overlaps with several of Biogen's served categories.
• Teleflex: Teleflex manufactures and distributes interventional cardiology, vascular, and critical care devices with European commercial operations. Its cardiovascular specialty and direct European footprint make it a comparable broad incumbent in Biogen's served categories.
• Cardinal Health: Cardinal Health is one of the largest global medical product distributors with extensive hospital and lab supply operations across Europe. While not cardiology-specialized, its distribution scale and hospital reach make it a comparable broad incumbent in medical device distribution.
• Abbott: Abbott operates a major cardiovascular and diagnostics business with direct sales in Iberia. Its portfolio overlaps with Biogen's interventional cardiology, electrophysiology, and laboratory diagnostic categories, and competes for the same hospital accounts.
• Edwards Lifesciences: Edwards Lifesciences is a global leader in structural heart and critical care monitoring, with direct operations in Iberia. Its portfolio overlaps directly with Biogen's interventional cardiology, valvuloplasty, and hemodynamic monitoring categories.

Others

• Terumo: Terumo is one of Biogen Diagnóstica's principal distribution partners for cardiovascular and interventional products in Spain and Portugal. It is included as a key OEM relationship rather than a competitor, illustrating the upstream supply side of Biogen's distribution business.

Direct peers

• Izasa Scientific (Werfen): Izasa Scientific is the Iberian distribution arm of Werfen, supplying hospitals and labs with diagnostic and medical device products in Spain and Portugal. Its specialty distribution profile and Iberian footprint mirror Biogen Diagnóstica's go-to-market approach.
• Palex Medical: Palex Medical is a Spanish medical technology distributor serving hospitals and laboratories across Iberia with a broad multi-specialty portfolio. It is the closest direct comparable to Biogen Diagnóstica in terms of regional focus, customer base, and distribution-plus-proprietary model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biogen-diagnostica

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biogen Diagnostica